The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: A multi-institutional analysis.
Takuya Koie(Hirosaki University), Takahiro Yoneyama(National Institute of Technology and Evaluation), Sadafumi Kawamura(Miyagi Prefectural Hospital Organization), Shintaro Narita(Akita University), Takamitsu Inoue(International University of Health and Welfare), Koji Mitsuzuka(Pacific Northwest Diabetes Research Institute), Chikara Οhyama(Hirosaki University), Yoichi Arai(Japan Atomic Energy Agency), Teppei Ookubo(Tohoku University), Tatsuo Tochigi(Miyagi Prefectural Hospital Organization), Tomonori Habuchi(Akita University)
Cited by 0
Related Papers
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes
|Genome Research|2005|506
Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial
|Journal of Clinical Oncology|2013|253